// App-Quantinova.ai

8550 : Multimodality therapy in IIIA-N2 NSCLC: Factors associated with treatment selection and survival.

Researchers

Presenter

  • Andrew Brandmaier

Principal Investigators

  • Elizabeth Mauer

  • Paul J. Christos

  • Dattatreyudu Nori

  • Silvia Formenti

  • Himanshu Nagar

Medical Centers

  • New York Presbyterian Weill Cornell Medical Center, New York, NY

  • New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY

  • New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY

  • New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved